Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

205
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
205
Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

161
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
161
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

245
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
245
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Gut mycobiota alteration contributes to the pathogenesis of Pneumocystis pneumonia.

Journal of translational medicine·2026
Same author

Prognostic factors and a nomogram for survival in anti-MDA5 antibody-positive dermatomyositis-associated interstitial lung disease.

BMC pulmonary medicine·2025
Same author

Increased in-hospital mortality and readmission risk associated with cardiovascular and cerebrovascular comorbidities in acute exacerbation of COPD patients.

BMJ open respiratory research·2025
Same author

Blood Eosinophil Stability Predicts Clinical Outcomes in Hospitalized Patients with Acute Exacerbations of COPD.

International journal of chronic obstructive pulmonary disease·2025
Same author

Plasma Proteomic Profiling Yields a High-Performance Biomarker Panel for Predicting a Poor Prognosis in Patients with COVID-19.

Journal of proteome research·2025
Same author

Clinical Characteristics and Treatment Efficacy in Patients With SARS-CoV-2 Positivity After Nirmatrelvir-Ritonavir Therapy.

Journal of medical virology·2025

相关实验视频

Updated: Jul 1, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K

使用常规生物标志物超越乙氨基酸水平的综合性诺姆图:在AECOPD中提高皮质类固醇治疗结果的可预测性

Lin Feng1, Jiachen Li1, Zhenbei Qian2

  • 1Department of Clinical Epidemiology, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People's Republic of China.

Journal of inflammation research
|March 13, 2024
PubMed
概括

预测慢性阻塞性肺病 (AECOPD) 急性恶化的皮质类固醇治疗成功,可以通过将血中乙氨基酸细胞计数与其他临床因素结合起来来改善. 新的评分系统为预测AECOPD患者治疗结果提供了适度的增强.

关键词:
慢性阻塞性肺病 慢性阻塞性肺病葡萄糖皮质类药物是什么最小绝对收缩和选择操作员的选择.预测模型 预测模型

更多相关视频

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

263
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
00:07

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.7K

相关实验视频

Last Updated: Jul 1, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

263
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
00:07

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.7K

科学领域:

  • 肺部医学 肺部医学
  • 临床生物标志物 临床生物标志物
  • 预测建模预测建模

背景情况:

  • 慢性阻塞性肺病 (AECOPD) 的急性恶化表现出对皮质类固醇治疗的不同反应.
  • 预测治疗成功对于优化患者管理至关重要.

研究的目的:

  • 评估是否将血中乙氨基酸水平与常规临床指标相结合,可以改善AECOPD中对皮质类固醇治疗结果的预测.
  • 开发一个评分系统,用于预测AECOPD中的治疗失败.

主要方法:

  • 对3254名AECOPD患者接受皮质类固醇治疗的回顾性分析.
  • 利用LASSO和后勤回归来进行预测器选择,并开发了预测性名ograms.
  • 使用AUC,校准图表,引导验证和决策曲线分析来评估nomogram性能.

主要成果:

  • 在24.7%的患者中观察到治疗失败.
  • 为吸烟者和非吸烟者开发了不同的名录,包括乙酸蛋白,血小板,CRP,LDL胆固醇,PNI,之前的AECOPD住院,缺血性心脏病和慢性肝病.
  • 诺莫图表显示出适度的预测优越性,仅比单独的乙素水平 (AUC 0.644-0.647).

结论:

  • 开发了使用易于使用的诺姆图,使用可访问的炎症,营养和免疫的生物标志物.
  • 这些名谱在预测皮质类固醇治疗的AECOPD患者的治疗结果方面提供了适度的改善.
  • 需要进一步研究新的生物标志物和额外的数据,以提高预测准确度.